Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
A summary is below
GLP-1 analogs demonstrated efficacy in cases refractory to other treatment modalities, often in cases of patients with obesity who would experience additional benefits from starting therapy
Injectable formulations require correct site rotation, appropriate storage, and product-specific missed-dose protocols as detailed in the patient information leaflet
Safety is still being characterized Without an FDA-approved label, retatrutide has no official adverse-reaction profile, boxed warnings, contraindications, or prescribing instructions
US$ 24.79
US$ 27.86
US$ 29.79
US$ 23.60
US$ 20.85
